TMC207 is a first-in-class anti-TB diarylquinoline (also named R207910 or the 'J' compound) with activity against drug-sensitive and drug-resistant TB. TMC207 inhibits the proton pump of mycobacterial ...
* Anti-TB compounds show promise to treat Chagas, others * Gates Foundation backs dealbtw non-profit drug developers (Corrects 5th para to delete reference to PA-824 being covered) GENEVA, July 7 ...
A new study identified that a semi-synthetic compound can be derived from natural compounds and shows potent activity against tuberculosis (TB), including multi-drug resistant TB. A new study ...
Antimicrobial stewardship (AMS) refers to coordinated strategies for the targeted, evidence-based, and safe use of ...
An international research team headed by scientists at the University of British Columbia has demonstrated how a novel semi-synthetic compound derived from sanguinarine (SG), an alkaloid extracted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback